<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Neuropeptide Y (NPY) has been demonstrated in the human circle of Willis by specific radioimmunoassay </plain></SENT>
<SENT sid="1" pm="."><plain>Concentrations were similar in cadaver and peroperative specimens </plain></SENT>
<SENT sid="2" pm="."><plain>NPY concentrations were highest around the basilar bifurcation (2.9 +/- 1.0 pmol/g), anterior cerebral artery (2.7 +/- 0.5 pmol/g), and carotid trifurcation (2.4 +/- 0.6 pmol/g) </plain></SENT>
<SENT sid="3" pm="."><plain>Concentrations were lowest in the basilar artery (1.0 +/- 0.4 pmol/g) </plain></SENT>
<SENT sid="4" pm="."><plain>Intracarotid administration of NPY (50 pmol to 2 nmol) to rats reduced mean cerebral cortical blood flow by 40-98% </plain></SENT>
<SENT sid="5" pm="."><plain>This vasoconstriction lasted for at least 2 h </plain></SENT>
<SENT sid="6" pm="."><plain>These findings suggest that NPY may be involved in the <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> which follows <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> and in the maintenance of <z:mpath ids='MPATH_458'>normal</z:mpath> vascular tone </plain></SENT>
</text></document>